Eli Lilly's Covid-19 antibody drug treatment gets emergency USFDA clearance
The FDA authorised the experimental treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adults, including those who are 65 and older, and pediatric patients
No comments:
Post a Comment